ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 731703 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 731703; 2) Community: the network communities that were significantly associated with the response to NSC 731703; 3) Molecule: the relationships between components within communities and NSC 731703; 4) MDR: the compounds that were significantly associated with the NSC 731703.

NSC Compound Enrichment Correlation
NSC 711175 Null 0.0386895225700407 0.14664857
NSC 711806 Null 0.0386895225700407 -0.027510955
NSC 714663 Null 0.0386895225700407 0.13387634
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.0386895225700407 0.15596919
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0386895225700413 0.31842047
NSC 732844 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-fluorobenzene 0.0386895225700413 0.11087407
NSC 736116 6-(3-Amonopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride 0.0386895225700413 0.11733312
NSC 758664 Sirolimus [USAN] 0.0386895225700413 -0.29038551
NSC 758682 ARTENIMOL 0.0386895225700413 0.23510324
NSC 94600 Camptothecin 0.0386895225700413 -2.9766102e-005
Total:53  Current:43    [First] [Prev] [Next] [Last]